PRE-CONFERENCE WORKSHOP – MICROBIOME DRUG DISCOVERY: PAST, PRESENT AND FUTURE

Workshop Leaders

Date: 11 September 2023
Time: 2.00-3.30pm

This session addresses the following points:

• Lessons learnt from the last 10 years in microbiome biotech
• The impact of recent FDA approvals on biotech and investing in the microbiome
• Current thinking on drug modality – FMT, LBP, metabolite, drugs that target the microbiome, etc
• Current “mood” of pharma to the microbiome space
• Microbiome technologies and advances on the near horizon
• Challenges ahead for the next few years
• Prospects of therapeutics vs direct-to-consumer products

Prof. Mazmanian’s laboratory at Caltech studies the human gut microbiome with a focus on developing novel therapies for immunologic and neurologic disorders, including Inflammatory Bowel Disease, Autism Spectrum Disorder, and Parkinson’s disease. He has been a principal investigator on 13 NIH grants, and numerous foundation and industry-sponsored projects. His research accomplishments have been recognized through many awards, including a Searle Scholarship, Damon Runyon Innovation Award, Catalyst Award (UCLA), Discover Magazine’s “Best Brains in Science under 40”, a MacArthur Foundation “Genius” Award, and the DuPont-Danisco Microbiome Science Award.

*Limited slots available